Abstract
Introduction

Viral infections have been one of the major causes of non-relapse morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HCT) for hematological malignancy (1). With the development of early detection methods and preemptive therapy for viremia, and the advent of new anti-viral drugs, there has been significant progress in the management of some viral infections, such as that of herpes zoster, herpes simplex and cytomegalovirus (1, 2). At the same time, however, other viruses have had more important roles in the HCT setting, such as adenovirus (ADV), herpesviruses 6-8, community respiratory viruses, papovaviruses, parvovirus B19, enteroviruses, rotavirus and Norwalk virus (3). Among these, ADV infection is the third most virulent among HCT recipients
, and it is a significant cause of morbidity and mortality in patients after HCT, although the reported mortality rate varies from five to eightythree percent (1, (7) (8) (9) (10) 
o w T r a n s p l a n t a t i o n 
Methods
Histological evaluation of liver necropsy specimen
The postmortem liver specimen was processed for hematoxylin-eosin stains using standard protocols. Im (Fig. 1a) (Fig. 1b) . Electron micrographs showed a combination of intranuclear ring-like inclusions and virus particles of approximately 60-70 nm within the nucleus, highly indicative of ADV (Fig. 1c) . The crystalline arrays were not observed (8, (11) (12) (13) , and suspected in three cases (5, 14, 15) , one of which was treated with steroids (14) ; the treatment was not described in the other cases. (5, 14, 17) , and became prominent when liver failure ensued, reaching 6.1 times the upper limit of the normal value (14) . As for the physical signs and symptoms, fever (14, (16) (17) (18) , tender hepatomegaly (16) , or abdominal and back pain (18) were described at the onset in the previous cases. The present case also presented with fever and abdominal cramping, which might have been the signs and symptoms of the disease, although both were also non-specific.
Results
Hematoxylin-eosin staining of the liver necropsy specimens showed large and random foci of coagulative hepatocyte necrosis with mild canalicular and cytoplasmic cholestasis and some steatosis, surrounded by hepatocytes with ill-defined intranuclear basophilic inclusions and chromatin margination, or 'smudge cells', characteristic of adenovirus infection
I mmu n o h i s t oc h e mi c a l s t a i n i n g wi t h a n t i -ADV a n t i b o d y , c ) T r a n s l u c e n t e l e c t r o n mi c r o s c o p y o f f o r ma l i n -f i x e d p a r a f f i n -e mb e d d e d l i v e r s p e c i me n . T h e b l a c k l i n e a t t h e b o t t o m i n d i c a t e s a l e n g t h o f 2 0 0 n m. T a b l e 2 . P r e v i o u s Ca s e s wi t h Ad e n o v i r a l F u l mi n a n t He p a t i c F a i l u r e a f t e r He ma t o p o i e t i c Ce l l T r a n s p l a n t a t i o
The clinical pictures of ADV fulminant hepatic failure depicted in the previous reports are almost identical. The elevation of liver enzyme is prominent; up to 205 times the upper limit of the normal value for alanine aminotransferase (ALT) (16), up to 269 times the upper limit of the normal value for aspartate aminotransferase (AST) (16), up to 8 times the upper limit of the normal value for alkaline phos-phatase (5), and the elevation occurred rapidly. Of note, the AST level was higher than the ALT level, except in one report (14). The serum bilirubin level was not necessarily high when the other liver markers reached significance (16). The prolonged prothrombin time started at a moderate level, up to 1.4 to 1.8 times the upper limit of the normal value
In terms of diagnosis, liver biopsy was performed in only one case (5) (11, 19) , one case with donor lymphocyte infusion (20) , and the others without. All of the patients died.
Discussion
Among ADV diseases after HCT, fulminant hepatic failure is a rare manifestation (21) . We searched the literature extensively using PubMed Central, and found sixteen reported cases, summarized in Table 2 . Despite its rarity, adenovirus fulminant hepatic failure poses diagnostic and therapeutic challenges after HCT, due to its aggressive clinical course and extremely poor prognosis. In addition to HCT, some patients were reported to have developed fulminant hepatic failure after liver transplantation (22) (23) (24) (25) (26) (27) or renal transplantation (28) , or after chemotherapy without undergoing HCT (29) (30) (31) (32) (33) . Moreover, other cases were reported without having had any immunosuppressive treatment (34) , or some were immunocompetent cases (35, 36) .
Bordigoni et al (7) revised the Wisconsin criteria, which defines definite ADV disease as the presence of typical ADV nuclear inclusion in routine histopathology and/or a positive culture from affected tissue, originally described by Flomenberg et al (12) (2, 8, 11-13, 21, 39) , the intensity of immunosuppressive therapy (38) , the isolation of ADV from two or more sites (12, 39) , HLA-mismatched or unrelated transplants (1, 21) , T-cell depletion transplants (11) with/ without ATG, CD34+ positive selection transplant, lymphocytopenia (11) , ADV antibody status of the donors (2) , allogeneic transplantation (38, 39) , and a conditioning regimen with TBI (8) . No (17, 19) , 5 (14-16, 18) , and 32 (40) (41) , serum (42, 43) , or urine (42, 44) (41) .
Therapeutic options for ADV disseminated disease are still very limited (1, 7, 10, 36, 38, 39, 41, 43, (45) (46) (47) . Intravenous or aerosolized ribavirin (1, 7, 19, 38, 45, 47) , vidarabine (7) , and cidofovir (7, 36, (45) (46) (47) are included in antiviral agents, and the intravenous administration of immunoglobulin (12) , the discontinuation of antibiotics (36) , donor lymphocyte infusion (7) (38) . Although limited, however, early diagnosis and preemptive therapy might be the best hope (39, 43 
